Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
47,907,362
-
Share change
-
+4,630,428
-
Total reported value
-
$629,994,430
-
Put/Call ratio
-
0%
-
Price per share
-
$13.15
-
Number of holders
-
120
-
Value change
-
+$67,750,151
-
Number of buys
-
62
-
Number of sells
-
52
Institutional Holders of DECIPHERA PHARMACEUTICALS IN - COM (DCPH) as of Q2 2022
As of 30 Jun 2022,
DECIPHERA PHARMACEUTICALS IN - COM (DCPH) was held by
120 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,907,362 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BlackRock Inc., ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, STATE STREET CORP, GOLDMAN SACHS GROUP INC, Polar Capital Holdings Plc, Redmile Group, LLC, New Leaf Venture Partners, L.L.C., and Avidity Partners Management LP.
This page lists
120
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.